NCT03861286View on ClinicalTrials.gov

Haemostatic Markers in Cardiopulmonary Bypass

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

July 18, 2019

Study Completion Date

July 18, 2019

Conditions
Unfractionated HeparinCardiopulmonary Bypass Surgery
Trial Locations (1)

SW3 6NP

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT03861286 - Haemostatic Markers in Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter